214 The KRASG12D(ON) covalent tricomplex inhibitor RM-044 increases tumor antigen presentation and TCR repertoire diversity to promote anti-tumor immunity in a preclinical model of... by Nataliya Tovbis Shifrin, Marie Menard, Haley Courtney, Swetha Ganesh, Alice Kumamoto, Lillian Seu, Jacqueline AM Smith, Elsa Quintana

Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth. by Marie Ménard, Clélia Costechareyre, Gabriel Ichim, Jonathan Blachier, David Neves, Loraine Jarrosson-Wuilleme, Reinhard Depping, Jan Koster, Pierre Saintigny, Patrick Mehlen, Servane Tauszig-Delamasure

Get full text